Left Atrial Appendage Closure Devices Market Size

Left Atrial Appendage Closure Devices Market Size

The global left atrial appendage closure devices market size was valued at USD 1.8 billion in 2023 and is expected to exhibit growth at a CAGR of 19.2% from 2024 to 2032. The increasing prevalence of atrial fibrillation, favorable government initiatives, and technological advancements, among others, are some of the key variables driving the industry growth.

To get key market trends

  Download Free Sample

Left atrial appendage closure procedures that utilize LAA occlusion devices are crucial in reducing the stroke risk associated with atrial fibrillation. These procedures are beneficial to patients who need heart surgery and also have atrial fibrillation. As per a recent research study, over 10,000 cardiac surgery records observed that 37% of people had a left atrial appendage closure during their surgery in the U.S. Moreover, the Watchman device has been widely studied and has a proven record of safety after over 300,000 procedures performed across the globe with a remarkable procedural success rate. Thus, it is projected that the market would be driven in the coming years by the huge potential of left atrial appendage closure devices.

Further, technological advancements in device design are enhancing procedural safety and efficacy, increasing global adoption. Supportive clinical guidelines and increased awareness of minimally invasive options are also fueling demand. Additionally, expanded healthcare expenditure, improved access to advanced cardiovascular devices, and increasing reimbursement for LAA procedures in various countries are driving market expansion worldwide.

Left atrial appendage (LAA) closure devices, also referred to as left atrial appendage occlusion devices, are devices that are used to reduce the risk of LAA blood clots from entering the bloodstream and causing stroke in patients with non-valvular atrial fibrillation (AF).